Out-Licensing
Alliance has two key development products and is at the stage where it wishes to discuss partnership opportunities for their development and marketing across Europe and the rest of the World:
ISPRELOR
25mcg misoprostol (with / without an applicator device) indicated for the treatment of induction of labour.
Please click here for further information on ISPRELOR.
POSIDORM
A novel 1.5mg surge-sustained formulation of melatonin indicated for the treatment of sleep disorders.
Please click here for further information on POSIDORM.